Regulation of Skp2 expression and activity and its role in cancer progression
- PMID: 20526532
- PMCID: PMC5763972
- DOI: 10.1100/tsw.2010.89
Regulation of Skp2 expression and activity and its role in cancer progression
Abstract
The regulation of cell cycle entry is critical for cell proliferation and tumorigenesis. One of the key players regulating cell cycle progression is the F-box protein Skp2. Skp2 forms a SCF complex with Skp1, Cul-1, and Rbx1 to constitute E3 ligase through its F-box domain. Skp2 protein levels are regulated during the cell cycle, and recent studies reveal that Skp2 stability, subcellular localization, and activity are regulated by its phosphorylation. Overexpression of Skp2 is associated with a variety of human cancers, indicating that Skp2 may contribute to the development of human cancers. The notion is supported by various genetic mouse models that demonstrate an oncogenic activity of Skp2 and its requirement in cancer progression, suggesting that Skp2 may be a novel and attractive therapeutic target for cancers.
Similar articles
-
Novel roles of Skp2 E3 ligase in cellular senescence, cancer progression, and metastasis.Chin J Cancer. 2012 Apr;31(4):169-77. doi: 10.5732/cjc.011.10319. Epub 2011 Dec 23. Chin J Cancer. 2012. PMID: 22200179 Free PMC article. Review.
-
Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex.Oncogene. 2013 Jan 3;32(1):78-85. doi: 10.1038/onc.2012.26. Epub 2012 Feb 6. Oncogene. 2013. PMID: 22310285 Free PMC article.
-
Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB.Nat Cell Biol. 2009 Apr;11(4):420-32. doi: 10.1038/ncb1849. Epub 2009 Mar 8. Nat Cell Biol. 2009. PMID: 19270694 Free PMC article.
-
Targeting the oncogenic E3 ligase Skp2 in prostate and breast cancer cells with a novel energy restriction-mimetic agent.PLoS One. 2012;7(10):e47298. doi: 10.1371/journal.pone.0047298. Epub 2012 Oct 12. PLoS One. 2012. PMID: 23071779 Free PMC article.
-
The Skp2 Pathway: A Critical Target for Cancer Therapy.Semin Cancer Biol. 2020 Dec;67(Pt 2):16-33. doi: 10.1016/j.semcancer.2020.01.013. Epub 2020 Feb 1. Semin Cancer Biol. 2020. PMID: 32014608 Free PMC article. Review.
Cited by
-
Lysosome-dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer.Mol Oncol. 2023 Oct;17(10):2126-2146. doi: 10.1002/1878-0261.13497. Epub 2023 Aug 21. Mol Oncol. 2023. PMID: 37491794 Free PMC article.
-
Beta-estradiol attenuates hypoxic pulmonary hypertension by stabilizing the expression of p27kip1 in rats.Respir Res. 2010 Dec 24;11(1):182. doi: 10.1186/1465-9921-11-182. Respir Res. 2010. PMID: 21182801 Free PMC article.
-
Anticancer and multidrug resistance-reversal effects of solanidine analogs synthetized from pregnadienolone acetate.Molecules. 2014 Feb 17;19(2):2061-76. doi: 10.3390/molecules19022061. Molecules. 2014. PMID: 24549231 Free PMC article.
-
Skp2-RNAi suppresses proliferation and migration of gallbladder carcinoma cells by enhancing p27 expression.World J Gastroenterol. 2013 Aug 14;19(30):4917-24. doi: 10.3748/wjg.v19.i30.4917. World J Gastroenterol. 2013. PMID: 23946596 Free PMC article.
-
Co-targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis.Prostate. 2024 Jun;84(9):877-887. doi: 10.1002/pros.24706. Epub 2024 Apr 11. Prostate. 2024. PMID: 38605532 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous